Transposon-activated POU5F1B Promotes Colorectal Cancer Growth and Metastasis
Overview
Authors
Affiliations
The treatment of colorectal cancer (CRC) is an unmet medical need in absence of early diagnosis. Here, upon characterizing cancer-specific transposable element-driven transpochimeric gene transcripts (TcGTs) produced by this tumor in the SYSCOL cohort, we find that expression of the hominid-restricted retrogene POU5F1B through aberrant activation of a primate-specific endogenous retroviral promoter is a strong negative prognostic biomarker. Correlating this observation, we demonstrate that POU5F1B fosters the proliferation and metastatic potential of CRC cells. We further determine that POU5F1B, in spite of its phylogenetic relationship with the POU5F1/OCT4 transcription factor, is a membrane-enriched protein that associates with protein kinases and known targets or interactors as well as with cytoskeleton-related molecules, and induces intracellular signaling events and the release of trans-acting factors involved in cell growth and cell adhesion. As POU5F1B is an apparently non-essential gene only lowly expressed in normal tissues, and as POU5F1B-containing TcGTs are detected in other tumors besides CRC, our data provide interesting leads for the development of cancer therapies.
RNF4 mediated degradation of PDHA1 promotes colorectal cancer metabolism and metastasis.
Chen J, Li Z, Zheng G, Cao L, Guo Y, Lian Q NPJ Precis Oncol. 2024; 8(1):258.
PMID: 39521913 PMC: 11550450. DOI: 10.1038/s41698-024-00724-5.
Proteomics Can Rise to the Challenge of Pseudogenes' Coding Nature.
Vasylieva V, Arefiev I, Bourassa F, Trifiro F, Brunet M J Proteome Res. 2024; 23(12):5233-5249.
PMID: 39486438 PMC: 11629383. DOI: 10.1021/acs.jproteome.4c00116.
Barai P, Biswas S, Verma P, Duncan E bioRxiv. 2024; .
PMID: 39071286 PMC: 11275719. DOI: 10.1101/2024.07.20.604429.
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer.
Cyberski T, Singh A, Korzinkin M, Mishra V, Pun F, Shen L NPJ Precis Oncol. 2024; 8(1):114.
PMID: 38783041 PMC: 11116544. DOI: 10.1038/s41698-024-00606-w.
Towards targeting transposable elements for cancer therapy.
Liang Y, Qu X, Shah N, Wang T Nat Rev Cancer. 2024; 24(2):123-140.
PMID: 38228901 DOI: 10.1038/s41568-023-00653-8.